Vyvanse still scarce

TGA may have been premature in declaring supply shortages of Vyvanse are “resolved”, a pharmacist says  Securing supplies of various strengths of ADHA medication, Vyvanse (lisdexamfetamine dimesilate) is continuing to challenge pharmacists despite the Therapeutic Goods Administration (TGA) declaring that shortages have been “resolved”.  Capital Chemist Group general manager, Andrew Topp, told the AJP that